Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery

被引:129
作者
Pandey, R [1 ]
Ahmad, Z [1 ]
Sharma, S [1 ]
Khuller, GK [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India
关键词
nanoparticles; clotrimazole; econazole; polylactide-co-glycolide; alginate;
D O I
10.1016/j.ijpharm.2005.05.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to improve the oral bioavailability of two clinically important antifungal drugs clotrimazole and econazole. Each drug was encapsulated in nanoparticles of a synthetic polymer (polylactide-co-glycolide, PLG) or a natural polymer (alginate stabilized with chitosan). The nanoparticles were prepared by the emulsion-solvent-evaporation technique in case of PLG and by the cation-induced controlled gelification in case of alginate. Drug encapsulation efficiency was better (>90%) for the alginate formulation compared with the PLG formulation (nearly 50%). The formulations were orally administered to mice and the drugs were analyzed in plasma by 4 validated HPLC technique. The biodistribution/pharmacokinetic data suggested that there was a controlled drug release for 5-6 days with each of the formulations, compared with unencapsulated drugs, which wer ,cleared within 3-4 h of oral/intravenous administration. There was a striking improvement in the relative and absolute bioavailability of each drug. Further, the. drugs were detected in the tissues (lungs,. liver and spleen) till 6-8 days in case of nanoparticles whereas free drugs were cleared by 12 h. Overall, the alginate formulation appeared to be better than the PLG formulation. The results emphasize the power of nanotechnology to make the concept of enhancement in oral bioavailability of azole antifungal drugs come to reality. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:268 / 276
页数:9
相关论文
共 20 条
[1]   Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration [J].
Ahlin, P ;
Kristl, J ;
Kristl, A ;
Vrecer, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :113-120
[2]   PLGA nanoparticles in drug delivery: The state of the art [J].
Bala, I ;
Hariharan, S ;
Kumar, MNVR .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (05) :387-422
[3]   Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin [J].
Cavalli, R ;
Bargon, A ;
Podio, V ;
Munton, E ;
Zara, CP ;
Gasco, MR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :1085-1094
[4]  
FROMTILING R A, 1988, Clinical Microbiology Reviews, V1, P187
[5]   Chitosan-based gastrointestinal delivery systems [J].
Hejazi, R ;
Amiji, M .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) :151-165
[6]   Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit [J].
Horisawa, E ;
Hirota, T ;
Kawazoe, S ;
Yamada, J ;
Yamamoto, H ;
Takeuchi, H ;
Kawashima, Y .
PHARMACEUTICAL RESEARCH, 2002, 19 (04) :403-410
[7]   EFFECT OF CYCLODEXTRIN ON THE PHARMACOLOGY OF ANTIFUNGAL ORAL AZOLES [J].
HOSTETLER, JS ;
HANSON, LH ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :477-480
[8]   In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits [J].
Jiao, YY ;
Ubrich, N ;
Marchand-Arvier, M ;
Vigneron, C ;
Hoffman, M ;
Lecompte, T ;
Maincent, P .
CIRCULATION, 2002, 105 (02) :230-235
[9]   Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification [J].
Lamprecht, A ;
Ubrich, N ;
Pérez, MH ;
Lehr, CM ;
Hoffman, M ;
Maincent, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :97-105
[10]   Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model [J].
Pandey, R ;
Khuller, GK .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :266-268